Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer

BACKGROUND: Palbociclib administered with endocrine therapy was tolerable when the overall incidence of toxicities was assessed separately for three PALOMA studies. This study analyzed pooled, longer-term PALOMA safety data longitudinally. METHODS: Data were pooled from three randomized phase II and...

Descripción completa

Detalles Bibliográficos
Autores principales: Diéras, Véronique, Rugo, Hope S, Schnell, Patrick, Gelmon, Karen, Cristofanilli, Massimo, Loi, Sherene, Colleoni, Marco, Lu, Dongrui R, Mori, Ave, Gauthier, Eric, Huang Bartlett, Cynthia, Slamon, Dennis J, Turner, Nicholas C, Finn, Richard S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449170/
https://www.ncbi.nlm.nih.gov/pubmed/30032196
http://dx.doi.org/10.1093/jnci/djy109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449170/
https://www.ncbi.nlm.nih.gov/pubmed/30032196
http://dx.doi.org/10.1093/jnci/djy109

Ejemplares similares